50 million people worldwide are living with dementia. Population aging is expected to more than triple numbers by 2050. Dementia encompasses multiple degenerative brain disorders that are progressive, cannot be cured, continuously diminish cognitive and functional abilities, cause neuropsychiatric symptoms, and ultimately lead to death. Yet even in the face of profound impairment, people with dementia can maintain QoL with appropriate supports in place. With no dementia cure or disease-modifying treatment available, maximizing QoL is the one thing we can do for people with dementia. Therefore, persons with dementia and agencies that advocate for them demand that maximizing QoL is a priority goal in Canada and worldwide. Before we can implement system-wide routine measurement, we have to test whether it is feasible to do so. Therefore the ultimate benefit of this study will be establishing a feasible approach to routine QoL measurement in designated supportive living (DSL) and nursing home (NH) sites. This study will be the prerequisite to actually monitoring and improving QoL in DSL and NH residents with dementia.
Funded by:
Alzheimer Society Research Program Quality of Life New Investigator grant: Grant/award #21-16